A Profile of the Indian Pharmaceutical Companies

Mithun Nandy ()
Additional contact information
Mithun Nandy: Hegde & Hegde Pharmaceutica LLP

Chapter Chapter 2 in Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry, 2022, pp 29-47 from Springer

Abstract: Abstract Before going to the detailed discussion of Indian pharmaceutical companies’ profile, it’s better to have a crystal clear idea pertain to the structural overview of pharmaceutical industry of Indian where different pharmaceutical companies operate and conduct manifold activities. In India, different pharmaceutical companies target a specific segment or a group of segments and accordingly design and decide their product portfolio for serving to the needy patient fraternities by serving different drug products and healthcare solutionHealthcare solution.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-981-16-6921-7_2

Ordering information: This item can be ordered from
http://www.springer.com/9789811669217

DOI: 10.1007/978-981-16-6921-7_2

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().